helvetixpharma[.]com

Analysis of the domain helvetixpharma.com indicates a high risk of being involved in phishing activities. The domain was created on April 28, 2026, and is currently active, suggesting a relatively recent and ongoing operation. The domain's infrastructure, including nameservers dns1.namecheaphosting.com and dns2.namecheaphosting.com, points to a hosting service that is often associated with malicious activities, raising immediate red flags. Additionally, the domain resolves to the IP address 198.177.120.75, which is located in the Netherlands and is associated with the web hosting provider Web-hosting.com, known for hosting a variety of suspicious and malicious sites. The domain's SSL certificate, issued by Sectigo Limited, is a standard DV (Domain Validation) certificate, which does not provide strong identity verification and can be easily obtained by malicious actors to appear more legitimate to potential victims. The domain appears on one security blocklist and is blocked by PhishDestroy, further confirming its association with phishing. While 3 out of 95 security vendors on VirusTotal flag this domain, the relatively low detection rate does not necessarily indicate safety, as phishing domains can be designed to evade detection by certain security tools. Defenders should be cautious and implement additional layers of security, such as DNS-based filtering, to prevent access to this domain. Monitoring for any suspicious emails or web traffic related to helvetixpharma.com is also recommended, as the domain could be part of a broader phishing campaign targeting sensitive information or credentials.